Apimeds Pharmaceuticals US, Inc. (APUS)
1.51
+0.14
(+10.22%)
USD |
NYAM |
May 15, 16:00
1.44
-0.07
(-4.64%)
After-Hours: 20:00
Apimeds Pharmaceuticals US EPS Diluted (Quarterly) : -0.0919 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Savara, Inc. | -0.1472 |
| Biogen, Inc. | 2.153 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.155M |
| Total Expenses (Quarterly) | 1.155M |
| Enterprise Value | 15.19M |
| Earnings Yield | -32.85% |
| Normalized Earnings Yield | -39.82 |